Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: 0.00 (0.00%)
Spread: 0.50 (7.407%)
Open: 7.00
High: 7.00
Low: 7.00
Prev. Close: 7.00
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Mar 2019 07:00

RNS Number : 6538S
IXICO plc
13 March 2019
 

 

IXICO plc

("IXICO" or the "Company")

 

Director and PDMR share purchase

IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, announces that it received notification on 12 March 2019 that Giulio Cerroni, Chief Executive Officer of the Company, acquired 53,300 ordinary shares of 1p each ("Ordinary Shares") at a price of 28 pence each.

 

Following this purchase, Giulio Cerroni is interested in 84,850 Ordinary Shares, representing 0.2 per cent. of the current issued share capital of the Company

 

 

For further information please contact:

 

IXICO plc

Giulio Cerroni, Chief Executive Officer

 

Tel: +44 20 3763 7499

Shore Capital (Nomad and Broker)

Edward Mansfield/Anita Ghanekar/Daniel Bush

Tel: +44 20 7408 4090

FTI Consulting Limited (Investor Relations)

Simon Conway/ Victoria Foster Mitchell / Tim Stamper

Tel: +44 20 3727 1000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Giulio Cerroni

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

IXICO plc

b)

 

LEI

 

 

2138005M1F59O6HWSA97

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares in IXICO plc

 

 

GB00BFXR4C20

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

28p per share

 

53,300 shares

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

N/A

 

 

N/A

 

e)

 

Date of the transaction

 

 

12 March 2019

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (IXI)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQLLFFKXFEBBB
Date   Source Headline
30th Jan 201710:28 amRNSResult of AGM
17th Jan 20174:09 pmRNSDirector/PDMR Shareholding
17th Jan 20177:00 amRNSAppointment of Giulio Cerroni as CEO
16th Jan 20172:00 pmRNSAnnual Report and Accounts and Notice of AGM
13th Jan 20173:25 pmRNSHolding(s) in Company
12th Jan 20172:56 pmRNSHolding(s) in Company
4th Jan 20173:43 pmRNSIssue of 590,093 Deferred Consideration Shares
23rd Dec 20167:00 amRNSBuyback and Cancellation of Deferred Shares
20th Dec 20167:00 amRNSFull Year Results
16th Nov 20167:00 amRNSParticipation in major EU partnership (ROADMAP)
21st Oct 20167:00 amRNSPre-Close Trading Update
20th Oct 20167:00 amRNS$1.2m contract with new global pharma customer
19th Oct 20167:00 amRNSIXICO presents at CAMD regulatory workshop
10th Oct 20167:00 amRNSEUR1m funding as a partner in major EU consortium
3rd Oct 20167:00 amRNSAppointment of Shore Capital as Nominated Adviser
3rd Oct 20167:00 amRNSAppointment of Shore Capital
26th Sep 20165:14 pmRNSDirector/PDMR Shareholding
26th Sep 20161:58 pmRNSExercise of Share Options
16th Sep 20167:00 amRNSBoard changes
13th Sep 20167:00 amRNSPresentation of Assessa® PML at ECTRIMS
29th Jul 201610:25 amRNSWeb-Based Technology Improves Paediatric ADHD Care
7th Jun 20167:00 amRNSHalf Yearly Report to 31 March 2016
2nd Jun 20167:00 amRNSCygnus joins Dementias Platform UK
4th Apr 20167:00 amRNSConsortium and Five Year Contract
31st Mar 20167:00 amRNSReal world study of Digital Biomarkers
31st Mar 20167:00 amRNSGrant of Awards to Directors
30th Mar 20167:00 amRNSNHS emergency and out-of-hours services contract
9th Mar 20169:30 amRNSEuropean research to tackle dementia
3rd Mar 20167:00 amRNSMehealth® used in American Academy of Pediatrics
1st Mar 201610:35 amRNSDirector/PDMR Shareholding
5th Feb 20167:00 amRNSDirector/PDMR Shareholding
4th Feb 20167:00 amRNSDirector/PDMR Shareholding
29th Jan 201610:45 amRNSResult of AGM
29th Jan 20167:00 amRNSAGM Statement
22nd Jan 20167:00 amRNSSelected for two NHS Innovation Test Beds
21st Jan 20167:00 amRNSMyBrainBook wins Regional Business Award
18th Jan 20167:00 amRNSFour contracts awarded worth over £3.0m
7th Jan 20167:00 amRNSFinancial Results for the year ended 30 Sept 2015
21st Dec 20152:03 pmRNSUpdate on Issued Share Capital
7th Dec 201510:04 amRNSResult of General Meeting
18th Nov 20153:45 pmRNSPublication of Circular
18th Nov 20157:00 amRNSProposed acquisition of Optimal Medicine & placing
2nd Nov 20153:38 pmRNSTotal Voting Rights
19th Oct 20157:00 amRNSPre-Close Trading Update
12th Oct 20151:16 pmRNSAdditional Listing
9th Oct 20157:00 amRNSCollaboration with leading pharmaceutical co in MS
2nd Oct 201511:18 amRNSExercise of Share Options
28th Aug 20157:00 amRNSIXICO awarded significant long-term contract
29th Jun 20157:00 amRNSVirtualScopics Alliance Update
25th Jun 20151:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.